Your session is about to expire
← Back to Search
Opioid Analgesic
Oxycodone Naloxone Combination for Chronic Pain
Phase 4
Waitlist Available
Led By Andrei Krassioukov, MD,PhD,FRCPC
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
Summary
This trial will compare the effectiveness of oxycodone-naloxone to regular opioids in treating chronic pain for those with spinal cord injuries.
Eligible Conditions
- Chronic Pain
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in management of pain related to spinal cord injury
Secondary outcome measures
Change from Baseline in depressive symptoms.
Change from Baseline in management of neurogenic bowel and opioid induced constipation
Change from Baseline in total daily dose of medications to manage bowel routine
+5 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Oxycodone Naloxone CombinationExperimental Treatment1 Intervention
Open-Label
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Oxycodone Naloxone Combination
2019
Completed Phase 4
~10
Find a Location
Who is running the clinical trial?
Purdue Pharma, CanadaIndustry Sponsor
8 Previous Clinical Trials
1,483 Total Patients Enrolled
Vancouver Coastal HealthOTHER_GOV
39 Previous Clinical Trials
717,169 Total Patients Enrolled
International Collaboration on Repair DiscoveriesOTHER
7 Previous Clinical Trials
224 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger